Tyler Engel
Tyler Engel is a principal and consulting actuary with the New York office of Milliman. He joined the firm in 2012.
Experience
Tyler provides a variety of skills, intelligence, and market strategy with a specialty in prescription drugs to a broad range of clients, including health plans, hospital systems, pharmaceutical companies, medical device manufacturers, healthcare industry trade organizations, disease and medical management vendors, and other healthcare providers.
For over a decade, he has helped these healthcare stakeholders address many new and arising challenges in the following areas:
- Market access strategy
- Medicare Part D filings
- Health Economics and Outcomes Research (HEOR)
- Evaluation of the cost effectiveness of care management programs
- Policy research and analysis
- Impact of the Inflation Reduction Act on Medicare Part D
Tyler is the editor and co-author of several publicly available white papers and peer review journal publications focused on health cost outcomes research and public policy.
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
- BS, Mathematics and Actuarial Science, University of Connecticut